Arnuparp Lekhakula

759 total citations
24 papers, 326 citations indexed

About

Arnuparp Lekhakula is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Arnuparp Lekhakula has authored 24 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 7 papers in Immunology. Recurrent topics in Arnuparp Lekhakula's work include Lymphoma Diagnosis and Treatment (11 papers), T-cell and Retrovirus Studies (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Arnuparp Lekhakula is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), T-cell and Retrovirus Studies (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Arnuparp Lekhakula collaborates with scholars based in Thailand, Israel and Germany. Arnuparp Lekhakula's co-authors include Tanin Intragumtornchai, Adam Lerner, Kenneth B. Hymes, Brad Pohlman, Ofer Shpilberg, Madeleine Duvic, Dina Ben‐Yehuda, Ranjana H. Advani, Uwe Hillen and M. Beylot‐Barry and has published in prestigious journals such as Blood, Cancer and British Journal of Haematology.

In The Last Decade

Arnuparp Lekhakula

22 papers receiving 318 citations

Peers

Arnuparp Lekhakula
Elizabeth Hodges United Kingdom
Akshaya Ramachandran United States
Ian H Gabriel United Kingdom
Sofía Garcés United States
Elizabeth Hodges United Kingdom
Arnuparp Lekhakula
Citations per year, relative to Arnuparp Lekhakula Arnuparp Lekhakula (= 1×) peers Elizabeth Hodges

Countries citing papers authored by Arnuparp Lekhakula

Since Specialization
Citations

This map shows the geographic impact of Arnuparp Lekhakula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnuparp Lekhakula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnuparp Lekhakula more than expected).

Fields of papers citing papers by Arnuparp Lekhakula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnuparp Lekhakula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnuparp Lekhakula. The network helps show where Arnuparp Lekhakula may publish in the future.

Co-authorship network of co-authors of Arnuparp Lekhakula

This figure shows the co-authorship network connecting the top 25 collaborators of Arnuparp Lekhakula. A scholar is included among the top collaborators of Arnuparp Lekhakula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnuparp Lekhakula. Arnuparp Lekhakula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lekhakula, Arnuparp, et al.. (2023). A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia. Annals of Hematology. 102(6). 1333–1340. 1 indexed citations
3.
Lekhakula, Arnuparp, Kanchana Chansung, Pimjai Niparuck, et al.. (2018). Impact of Early Switching to Nilotinib As Second Line TKI in Patients with Chronic Myeloid Leukemia Who Were Intolerant to, Suboptimal to and Failed Imatinib: The Thai Multi-Centered Study. Blood. 132(Supplement 1). 4267–4267. 1 indexed citations
4.
Chansung, Kanchana, Arnuparp Lekhakula, Pimjai Niparuck, et al.. (2016). Nilotinib As Second-Line Therapy in Patients with Chronic Myeloid Leukemia in Chronic Phase: Thailand Experience. Blood. 128(22). 5448–5448. 3 indexed citations
5.
Julamanee, Jakrawadee, Kanita Kayasut, & Arnuparp Lekhakula. (2015). The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL).. PubMed. 98(10). 950–6. 1 indexed citations
7.
8.
Chansung, Kanchana, Arnuparp Lekhakula, Jakrawadee Julamanee, et al.. (2015). Clinical Features and Treatment Outcomes of Angioimmunoblastic T-Cell Lymphoma: An Analysis from a Nationwide Multicenter Registry, Thailand. Blood. 126(23). 5064–5064. 1 indexed citations
9.
Foss, Francine M., Ranjana H. Advani, Madeleine Duvic, et al.. (2014). A Phase II trial of Belinostat ( PXD 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma. British Journal of Haematology. 168(6). 811–819. 161 indexed citations
10.
Intragumtornchai, Tanin, Udomsak Bunworasate, Noppadol Siritanaratkul, et al.. (2012). Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessability. Leukemia & lymphoma. 54(1). 83–89. 7 indexed citations
11.
Lekhakula, Arnuparp, et al.. (2012). Prognostic Significance of Serum Proangiogenic Molecules in Patients withDe NovoNon-Hodgkin Lymphomas. The Scientific World JOURNAL. 2012. 1–5. 1 indexed citations
12.
Kayasut, Kanita, et al.. (2011). No Prognostic Impact of p53 and P-Glycoprotein Expression in Patients with Diffuse Large B-Cell Lymphoma. ISRN Oncology. 2011. 1–6. 7 indexed citations
13.
Bunworasate, Udomsak, Arnuparp Lekhakula, Kanchana Chansung, et al.. (2011). A Nationwide Prospective Multicenter Study of Clinical Features and Outcomes of Non-Hodgkin Lymphoma in Thailand: An Analysis of 939 Cases. Blood. 118(21). 2064–2064. 3 indexed citations
14.
Lekhakula, Arnuparp, et al.. (2008). Incidence and Radiographic Findings of Primary Central Nervous System Lymphoma in Immunocompetent Patients in Southern Thailand. Tumori Journal. 94(3). 304–308. 3 indexed citations
15.
Kor‐anantakul, Ounjai & Arnuparp Lekhakula. (2007). Overt disseminated intravascular coagulation in obstetric patients.. PubMed. 90(5). 857–64. 13 indexed citations
16.
Kayasut, Kanita, et al.. (2007). A unique case of transient spontaneous regression complicated with tumor lysis syndrome of T-cell lymphoblastic lymphoma in HIV-infected patient without antiretroviral therapy.. PubMed. 90(9). 1930–3. 5 indexed citations
17.
Chuncharunee, Suporn, et al.. (2001). Treatment of Myelodysplastic Syndrome With Low-Dose Human Granulocyte Colony-Stimulating Factor: A Multicenter Study. International Journal of Hematology. 74(2). 144–146. 4 indexed citations
18.
Intragumtornchai, Tanin, et al.. (1996). Non‐Hodgkin's lymphomas in Thailand: A retrospective pathologic and clinical analysis of 1391 cases. Cancer. 78(8). 1813–1819. 36 indexed citations
19.
Kor‐anantakul, Ounjai, et al.. (1991). Cutaneous myiasis of vulva caused by the muscoid fly (Chrysomyia genus).. PubMed. 22(3). 458–60. 4 indexed citations
20.
Jaruratanasirikul, Sutep, Sineenart Kalnauwakul, & Arnuparp Lekhakula. (1987). Traumatic wound infection due to Bacillus cereus in an immunocompromised patient: a case report.. PubMed. 18(1). 112–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026